Patent Update: Cardiovascular & Renal: Endothelin receptor antagonists

This publication has 11 references indexed in Scilit:

• 1,3-Diarylindan-2-carboxylic Acids, Potent and Selective Non-Peptide Endothelin Receptor Antagonists
  Journal of Medicinal Chemistry, 1994
• Patent Update Cardiovascular & Renal: Treatments for myocardial ischaemia
  Expert Opinion on Therapeutic Patents, 1994
• The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion
  Cardiovascular Research, 1993
• Endothelin‐1 modulates vascular smooth muscle structure and vasomotion: Implications in cardiovascular pathology
  Drug Development Research, 1993
• Growth regulatory properties of endothelins
  Peptides, 1993
• Design of a functional hexapeptide antagonist of endothelin
  Journal of Medicinal Chemistry, 1992
• Contribution of endogenous endothelin to the extension of myocardial infarct size in rats.
  Circulation Research, 1991
• Hypertension Associated with Endothelin-Secreting Malignant Hemangioendothelioma
  Annals of Internal Medicine, 1991
• INCREASED PLASMA CONCENTRATIONS OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1989